Community/Retail

A recently-published study explores the outcomes associated with the combination of DOACs and dual anti platelet therapy.

CDC officials now recommend routine use of the meningococcal conjugate vaccine for patients with HIV.

Many students apply for pharmacy residencies without understanding their benefits and disadvantages.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Egalet has submitted a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse.

Founding partners of the Next-Generation Pharmacist awards Parata Systems and Pharmacy Times, the leading media resource for pharmacists and the pharmacy industry, are now accepting nominations for the 2017 awards program.

The FDA has approved Relypsa, Inc.’s supplemental New Drug Application (sNDA) with label updates of Veltassa (patiromer) for oral suspension. Veltassa was approved by the FDA for the treatment of hyperkalemia on October 21, 2015.

Flu vaccinations during pregnancy do not seem to increase risk of autism spectrum disorders in children, according to a report published in JAMA Pediatrics.

December 1 is observed as World AIDS Day.

A study that evaluated a phase 3 monoclonal antibody treatment that targeted Alzheimer’s disease, solanezumab (Eli Lilly), did not meet its primary endpoint in the EXPEDITION3 clinical trial, according to a statement from the company.

One entrepreneurial student had his first experience with pharmacy in high school, is that where we should be starting?

Opportunities for Ohioans with Disabilities has recognized Meijer as a Champion of Opportunity for its commitment and leadership in integrating individuals with disabilities into Ohio’s workforce.

According to the CDC, 82% of American adults take at least one medication and 29% take five or more.

​Albertsons Companies will have its name in lights on the University of Idaho campus with a commitment of $500,000 over the next 10 years to the new court-sports arena and naming rights to the scoreboard.

Officials with GlaxoSmithKline have received approval from the FDA’s Center for Biologics Evaluation and Research to expand the indication for FluLaval Quadrivalent to include use in children aged 6 months and older.

Individuals living with HIV have approximately a 50-50 chance of developing depression, which can cause adverse outcomes such as accelerated disease progression, suppressed immune function, and medication nonadherence.

APhA recently released a video celebrating 20 years of promoting pharmacist as immunizers.

Effective pharmacy management is about learning to be a servant to others. All of the responsibilities of a pharmacy manager can be generally grouped under 4 focuses of service.

As a pharmacy student assessing career options, you may think that employment with one of the major chains is the best, or even the only, viable path.

OptumRx and CVS Pharmacy have entered into a strategic relationship in an effort to bring together complementary capabilities to provide greater convenience and value.

A historic clinical trial testing the efficacy of an experimental HIV vaccine regimen gets underway this week in South Africa.

The likelihood of developing shingles triples at age 65 and its repercussions are significantly more serious than in younger adults. For this reason, the CDC has recommended the shingles vaccine for people aged 60 years or older since 2006.

Ajanta has launched aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States.

AJHP (American Journal of Health-System Pharmacy) today announced the launch of a redesigned website for the scholarly journal’s online presence, AJHP.org.

Pharmacists are slowly changing the way they deliver their services. Previous professional literature has demonstrated pharmacists' potential through studies of how clinical pharmacists improve care for patients in many settings, especially for diabetes.

The FDA has granted PhaseRx Inc. orphan drug designation for PRX-OTC, an intracellular enzyme replacement therapy that can potentially treat ornithine transcarbamylase deficiency (OTCD) in children.

Officials with Ascensia Diabetes Care have announced that the Contour Next One Blood Glucose Monitoring System has received FDA 510(k) clearance.